Immersionn™ is a Virtual Reality discovery engine for immersive content. This engine works with fast speeds and low latency providing 5G networks that are the perfect go-to-market vehicle for Immersionn. This platform is accessible via smartphones, virtual reality headsets and laptops. Immersionn has the potential to work globally with 5G Telco operators and other vertical markets (e.g Transport, Mobile OEMs) that benefit from proposing Immersionn’s offering to its customers. Immersionn’s founder is a member of the UK5G Creative Industries working group, supporting the acceleration of the immersive sector adoption of 5G.
days to go:
Expired
investment:
£110,300
Victor Mobility have designed a mobility device to bring a disabled person into an able bodied environment. The mobility device will be modular so it will adapt to the users disability, it will go up and down a kerb, it will go inside and out so you don't have to buy two devices and it will enable the user to be at social height or eye height of 1.5m.
days to go:
Expired
investment:
£716,150
Untied is a groundbreaking app that gathers information, claims costs and allowances, and prepares tax filings on the go. All of these can be sent to the tax authority from the application. The app connects across existing accounts, making tax sense of transactions and gives the assurance someone needs. Backed by Accenture's Fintech Innovation Lab and Barclays Techstars, the company became the first overseas winner of Israel's biggest fintech prize at Fintech Junction. The business will earn a turn over of £100m in ten years making it ready for an IPO. With the proceeds, it will create new software platforms, publishers, banks, and accounting firms.
days to go:
Expired
investment:
£350,000
Genomes.io is a safe and private DNA data storage application resolving the problem of DNA data breach and exploitation. It helps the users to store, manage, promote and arrange their genomic data in order. The company is a member of Consensys Labs Tachyon II Accelerator 2019. It has also signed MOU with TenX Health VC for lead investment and board position and, it is in discussions with Pharma & Biotech co for establishing partnerships. The company is seeking funds to bring its B2B and B2C products to market.
days to go:
Expired
investment:
£1,035,370
StanMe aims to be the first community marketplace to enable collaboration and co-selling between independent creators. It asserts that the majority of creators have to continuously learn techniques to market themselves, adapt to social platforms’ ever-changing algorithms, and grow and maintain a large community to generate a sufficient amount of sales. StanMe claims that not all can do so and intends to address this situation with its services. It launched its public beta in July 2020 with more than 1,000 users and has processed over 130 transactions since its beta launch. StanMe claims it has more than 1,900 pre-registered users on its waiting list and aspires to become a contender in the creator economy valued at $11 billion in 2019. It will use the investment to accelerate its growth, invest in technology, and boost marketing initiatives.
days to go:
Expired
investment:
£164,080
Zentraxa is focused on precision bioengineering to produce peptides with predictable properties tailored towards purpose. The company points out that peptides are amino acids that are the building blocks of certain proteins needed by the skin, like collagen and elastin. It has come out with a synthetic biology platform, Zentide, that designs, produces and tests novel peptides. Zentraxa argues that Zentide can circumvent previously existing bio-design limits imposed by conventional peptide synthesis and produce tailor-made biomaterials for healthcare, personal care and industrial uses. Zentraxa is initially targeting healthcare with its first biomaterial, a debondable adhesive, for use in wound care. The company asserts that the material has other uses such as cosmetics and industrial applications due to its ability to bond strongly while still being easily and painlessly removable. Zentraxa will use the investment to create a portfolio of other biomaterials for licensing to global businesses in the health and industrial sectors via its Zentide platform.
days to go:
Expired
investment:
£1,040,000
Bio Teq aim to be early movers in the human implantable technology market ebbedding micro-transponder technology into users hands. The company has already featured on BBC, Channel 5 and ITV News and is raising to further research and development.
days to go:
Expired
investment:
£39,770
Using the latest in Internet of Things (IoT) and low-power technology, Sensize has created a system to globally monitor supply chains. Trackers are fitted to reusable plastic crates, containers, cages and palettes. They are used to alert theft, record their location and detect the environment as they are transported through a supply chain.
days to go:
Expired
investment:
£149,240
At Wombat our mission is to empower generations to manage, save and grow their money. Our goal is to break down barriers that prevent people from investing. Wombat will allow people to invest in some of the world’s best known brands for as little as £5.
days to go:
Expired
investment:
£209,160
LetsBab is an online marketplace, where one can shop and share products with friends. The application pays people for the recommendations, which they can either keep or donate. The company has over 100 brands from high street to high end, from ASOS to Hunter. LetsBab's mobile commerce was worth over £1.4 trillion and global e-commerce sales were $2.3 trillion in 2017. The company has 16 charity partners which include Cancer Research & Women for Women, and it has been featured in the Observer, Marie Claire and Yahoo! Finance. LetsBab is seeking investment to grow its user base and invent new features to drive sales.
days to go:
Expired
investment:
£376,490
